Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy
Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy
www.nature.com Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy - Nature
Type 1 regulatory T cells (Tr1) represent a major obstacle that compromises naturally occurring and therapeutically induced tumour-specific immunity.
0
comments